| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/07/2005 | EP1104291B1 Pellets having a core coated with an antifungal and a polymer |
| 09/07/2005 | EP1037634B1 Oral administration form comprising a proton pump inhibitor (e.g.pantoprazole) |
| 09/07/2005 | EP0731694B2 Opioid formulations for treating pain |
| 09/07/2005 | CN1665933A Immunoconjugates for the treatment of tumours |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665862A Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665763A Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 09/07/2005 | CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
| 09/07/2005 | CN1665565A GHRELIN-carrier conjugates |
| 09/07/2005 | CN1665559A Method and packaging for pressurized containers |
| 09/07/2005 | CN1665544A Drug- or gene-carrier composition having lowered hemagglutinin activity |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors |
| 09/07/2005 | CN1665532A Calicheamicin derivative-carrier conjugates |
| 09/07/2005 | CN1665531A Cancer vaccines and methods of using the same |
| 09/07/2005 | CN1665529A Method to enhance an immune response of nucleic acid vaccination |
| 09/07/2005 | CN1665525A Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 09/07/2005 | CN1665519A Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 09/07/2005 | CN1665517A Ciclesonide-containing sterile aqueous suspension |
| 09/07/2005 | CN1665497A Use of rotigotine for treating the restless leg syndrome |
| 09/07/2005 | CN1665492A Platform for transdermal formulations (ptf) |
| 09/07/2005 | CN1665491A Microcapsules for the delayed, controlled release of perindopril |
| 09/07/2005 | CN1665490A 控释组合物 A controlled release composition |
| 09/07/2005 | CN1665488A Direct cellular energy delivery system |
| 09/07/2005 | CN1665487A Liposomal vaccine |
| 09/07/2005 | CN1665486A Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 09/07/2005 | CN1665485A Compositions and methods for amelioration of human female sexual dysfunction |
| 09/07/2005 | CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/07/2005 | CN1665483A Solid dispersion comprising two different polymer matrixes |
| 09/07/2005 | CN1665482A Methods and dosage forms for controlled delivery of oxycodone |
| 09/07/2005 | CN1665476A Method and composition for improving sensory characteristics of semisolid predominantly anhydrous |
| 09/07/2005 | CN1665401A Vitamin-containing system for stabilising the immune response of animals |
| 09/07/2005 | CN1663999A Chitosan water-retaining gel adhesive substrate materials and method for preparing same |
| 09/07/2005 | CN1663985A Biodegradable fluorescent polyphosphonitrile and process for synthesis therof |
| 09/07/2005 | CN1663615A Fructose injection of antibiotic medicine |
| 09/07/2005 | CN1663560A Transdermal drug administering system |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/07/2005 | CN1217665C Measalazine controlled redease oral pharmaceutical compositions |
| 09/07/2005 | CN1217659C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 09/07/2005 | CN1217657C Method of improving survival of patients |
| 09/07/2005 | CN1217638C Agents promoting laminin production in skin cells |
| 09/07/2005 | CN1217598C Coloration with pearly luster pigments in food and pharmaceutical sectors |
| 09/07/2005 | CN1217584C Effervescent green tea extract formulation |
| 09/06/2005 | US6939955 Hematopoietic growth factor inducible neurokinin-1 gene |
| 09/06/2005 | US6939912 Compositions comprising copolymers of N-vinylcarboxamides and monomers with a hydrophobic radical, and use of these copolymers |
| 09/06/2005 | US6939865 Cardiovascular disorders; antiarrhythmia agents |
| 09/06/2005 | US6939846 Use of a polypeptide for treatment of pruritis in animals |
| 09/06/2005 | US6939677 useful for detection, diagnosis, and treatment of breast cancer; Human milk fat globule ( HMFG) |
| 09/06/2005 | US6939569 Medical device having anti-infective and contraceptive properties |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939564 core of the supramolecular assembly, whereas the shell consists of uncharged hydrophilic polymers; inclusion of the hydrophobic co-monomers to the polyelectrolyte segment forming the micelle core leads to a structure of enhanced stability |
| 09/06/2005 | US6939562 Collagen/polysaccharide bilayer matrix |
| 09/06/2005 | US6939561 Methods and compositions for polyene antibiotics with reduced toxicity |
| 09/06/2005 | US6939560 Pharmaceutical composition having two coating layers |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/06/2005 | US6939557 biocompatible therapeutic article comprising, a macromer having polymerized end groups, precipitated human growth hormone, and a molecule or mixture of molecules which preferentially excludes proteins |
| 09/06/2005 | US6939550 Storage stability |
| 09/06/2005 | US6939542 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free |
| 09/06/2005 | US6939538 Extended release analgesic for pain control |
| 09/06/2005 | US6939530 Preparation of further diagnostic agents |
| 09/06/2005 | US6939376 Drug-delivery endovascular stent and method for treating restenosis |
| 09/06/2005 | CA2278025C Aqueous suspension for nasal administration |
| 09/06/2005 | CA2193329C Water soluble rapamycin esters |
| 09/06/2005 | CA2119516C Ointment for wound treatment |
| 09/06/2005 | CA2105652C Reducing wound scarring with antibodies to growth factors |
| 09/04/2005 | CA2491341A1 Topical formulations for treatment of rosacea |
| 09/01/2005 | WO2005080586A1 Fusion proteins containing recombinant cytotoxic rnases |
| 09/01/2005 | WO2005080582A1 Cytoplasmic localization dna and rna |
| 09/01/2005 | WO2005080567A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals |
| 09/01/2005 | WO2005080032A1 Process for producing iron colloid, and iron-colloid-bearing polymer micelle |
| 09/01/2005 | WO2005079879A1 Collagen gel and process for producing the same |
| 09/01/2005 | WO2005079861A2 Polymeric water soluble prodrugs |
| 09/01/2005 | WO2005079860A1 New complexes |
| 09/01/2005 | WO2005079859A1 Target directional carrier |
| 09/01/2005 | WO2005079858A1 Stable, palatable syrup containing ibuprofen and method of its preparation |
| 09/01/2005 | WO2005079857A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances |
| 09/01/2005 | WO2005079855A1 Saccharose-fatty- acid-based pentetration promoter |
| 09/01/2005 | WO2005079854A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 09/01/2005 | WO2005079852A2 Bacteriostatic esters for topical use |
| 09/01/2005 | WO2005079838A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 09/01/2005 | WO2005079830A1 Inhibitors of amyloid fibril formation and uses thereof |
| 09/01/2005 | WO2005079818A1 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss |
| 09/01/2005 | WO2005079816A1 An anti-cancer substance of polysaccharides, its preparation method and application |
| 09/01/2005 | WO2005079809A1 Transparent latanoprost eye drops |
| 09/01/2005 | WO2005079768A2 Amoxicillin instant granulate |
| 09/01/2005 | WO2005079765A1 Compositions for the treatment of nail and skin disorders |
| 09/01/2005 | WO2005079757A2 Therapeutic agent carrier compositions |
| 09/01/2005 | WO2005079749A2 Chitosan containing solution |
| 09/01/2005 | WO2005079747A1 Pharmaceutical preparation for the oral cavity |
| 09/01/2005 | WO2005079490A2 Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides |
| 09/01/2005 | WO2005079398A2 Drug conjugates |
| 09/01/2005 | WO2005079396A2 O,o'-amidomalonate and n,o-amidomalonate platinum complexes |
| 09/01/2005 | WO2005079155A2 Photoreactive compound specifically binding to calcium binding proteins |
| 09/01/2005 | WO2005066203A3 Targeted immunogens |
| 09/01/2005 | WO2005065682A3 Rabeprazole containing formulation |
| 09/01/2005 | WO2005065435A3 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 09/01/2005 | WO2005055949A3 Sustained release preparations composed of biocompatible complex microparticles |